Application of inhaled steroids in case of mild-to-moderate asthma

Inhaled corticosteroids are medicines that are administered in case of asthma by kids and adults. Individuals that have mild, moderate and severe asthma take these medications every day. These medicines prevent inflammation of the airways. Physicians supervise persons with this disease, regulating dosage schedule each 6 weeks.
Unfortunately, inhaled corticosteroids, like other preparations, may lead to undesirable results. Regular application of these drugs is associated with several risks. Is there any method for persons with asthma to prevent these problems?
A recent study has manifested that doctors should not recommend using these medications daily to individuals with mild-to-moderate asthma. This study turned out to be very valuable. It is likely to alter guidelines connected with treatment of asthma.
The research was conducted by specialists of the Texas Medical Brach in Galveston. The doctor William Calhoun and his colleagues enrolled 340 persons with asthma in the study. Several persons were given inhaled steroids each day; others used these drugs, when symptoms of asthma attacks appeared. Bronchial reactivity and functions of lungs were measured by the doctors during nine months. The results of the study manifested that there was not any significant difference between these two groups.
According to the scientists, if inhaled corticosteroids are applied, when symptoms occur, exacerbation can be prevented. Moreover, these products have prolonged action. It means that positive effects are felt even several days after usage. The specialists suggest that these products may be administered by persons with mild-to-moderate asthma only when symptoms appear.
Why is this study valuable? According to certain sources, 25 million Americans experience asthma. Of course, they must be treated. This piece of news must be valuable for them. Moreover, if inhaled corticosteroids are taken prolonged time, they may lead to severe negative results, such as hormonal imbalance, cataract, etc. So, if individuals that suffer from mild-to-moderate asthma don’t administer these products each day, they are more unlikely to get these negative effects.
Of course, it is early to change indications linked with treatment of asthma. But this research may induce conducting further studies that may lead to some changes.